drugset / Trial / NCT01005108

Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors

NCT01005108

Phase 2 Completed 120 enrolled Abramson Cancer Center at Penn Medicine
RandomizedParallel-groupTriple-blindTreatment

Summary

Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).

Timeline

Start
2009-01
Primary completion
2014-01-31
Completion
2014-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 900 mg

Indications

No indication recorded.